BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3398423)

  • 1. [Changes in blood composition during hemosorption in patients with terminal stage of chronic renal failure].
    Maksimenko VA; Belorusov OS; Panchina OI; Noskova LA; Marchenko AL
    Khirurgiia (Mosk); 1988 Apr; (4):85-8. PubMed ID: 3398423
    [No Abstract]   [Full Text] [Related]  

  • 2. [The duration of hemosorption in patients with chronic renal failure].
    Maksimenko VA; Belorusov OS; Gorbovitskiĭ EV; Mikhaĭlov IuE; Lanskaia IM
    Vestn Khir Im I I Grek; 1988 Jan; 140(1):134-6. PubMed ID: 3381390
    [No Abstract]   [Full Text] [Related]  

  • 3. [The morphological characteristics of the erythrocytes during hemosorption in patients with chronic kidney failure and suppurative intoxication].
    Samoĭlov MV; Danilkov AP; Kudriavtsev IuV; Naumov AG
    Urol Nefrol (Mosk); 1993; (1):34-7. PubMed ID: 7941124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood viscosity and the erythrocyte charge in patients with chronic kidney failure and suppurative intoxication and during the correction of these conditions by hemosorption and hemodialysis].
    Samoĭlov MV; Zakharchenko VN; Larionov SM; Naumov AG; Danilkov AP; Zakharova VD; Ivleva AI; Kudriavtsev IuV; Surikova TP
    Urol Nefrol (Mosk); 1993; (4):34-7. PubMed ID: 8310565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Function of the blood prekallikrein-kallikrein system of patients with terminal kidney failure as affected by hemosorption].
    Petrun' NM; Baran EIa; Krimkevich EI
    Urol Nefrol (Mosk); 1986; (6):41-4. PubMed ID: 2433828
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electromyography in patients in the terminal stages of chronic renal failure treated with regular hemodialysis and hemosorption].
    Ender LA; Lagutina TS; Cherniakov VL; Shcherbakova EO; Shcherbakov VA
    Urol Nefrol (Mosk); 1984; (5):57-62. PubMed ID: 6095507
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of hemodialysis and hemosorption on blood serum level of medium-molecular components in patients with chronic renal failure].
    Kozlov VV; Riabov SI; Dorofeeva TB; von Appen K; Spiridonov VN
    Ter Arkh; 1984; 56(7):77-81. PubMed ID: 6484840
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extracorporeal hemosorption, an effective means of controlling exogenous and endogenous intoxications].
    Vlasenko AN
    Klin Med (Mosk); 1980 Jun; 58(6):17-22. PubMed ID: 6995710
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of extracorporeal dialysis on the blood copper concentration and its relation to the hemoglobin level in patients with chronic renal failure].
    Weyde W; Adamiec R
    Pol Tyg Lek; 1983 Jan; 38(2):51-4. PubMed ID: 6856498
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in biochemical and hematological indices during hemosorption in the acute period of the crush syndrome].
    Mikaelian NP; Ul'ianov MI; Muranov OF
    Biull Eksp Biol Med; 1984 May; 97(5):551-4. PubMed ID: 6722329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Level of serum immunoglobulins and circulating immune complexes in patients with terminal kidney failure during hemosorption treatment].
    Drannik GN; Baran EIa; Dem'ianova TV; Osnadchuk LN
    Vrach Delo; 1985 Aug; (8):86-8. PubMed ID: 4072118
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibilities of hemosorption for increasing the effectiveness of treatment of patients with renal tuberculosis with chronic renal insufficiency].
    Strel'nikova VA; Mochalova TP
    Probl Tuberk; 1985; (9):48-50. PubMed ID: 4070221
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of hemosorption in chronic kidney failure].
    Riabov SI; Shostka GD; Lukichev BG; Spiridonov VN; Strelko VV
    Klin Med (Mosk); 1984 Jun; 62(6):50-6. PubMed ID: 6471799
    [No Abstract]   [Full Text] [Related]  

  • 14. [The evaluation of the efficacy of efferent therapy in patients with acute and chronic kidney failure by the spectrum of blood middle-molecule fractions].
    Kon'kova TA; Chudnovskaia MV; Golovanov SA
    Urol Nefrol (Mosk); 1994; (4):35-7. PubMed ID: 7985299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disorders of serum lipid and protein composition in patients with chronic renal failure].
    Markiewicz K; Walasek L; Lutz W
    Pol Tyg Lek; 1972 Jan; 27(4):131-3. PubMed ID: 5010168
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of hemosorption and hemodialysis in the treatment of chronic renal failure].
    Riabov SI; Shostka GD; Lukichev BG; Strelko VV; Spiridonov VN
    Ter Arkh; 1981; 53(6):15-21. PubMed ID: 7281026
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of hemosorption on indices of natural resistance in chronic kidney failure].
    Drannik GN; Dem'ianova TV; Seniuk OF; Siniĭchuk KhV; Gurinovich EA
    Vrach Delo; 1989 Jan; (1):16-8. PubMed ID: 2718434
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemosorption in clinical practice (review of the literature)].
    Ananchenko VG; Griaznova NA; Glukhovskaia NIa; Kravets TA; Gulevich NV
    Sov Med; 1981; (2):72-7. PubMed ID: 7017955
    [No Abstract]   [Full Text] [Related]  

  • 19. [High-molecular compounds in the erythropoietic disorder of patients in the terminal stage of chronic kidney failure].
    Gudim VI; Sukiasova TG; Ivanova VS; Gorbunova NA; Kozinets GI
    Patol Fiziol Eksp Ter; 1985; (6):66-71. PubMed ID: 4094808
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemosorption as a method of treating patients with chronic renal failure].
    Shumakov VI; Levitskiĭ ER; Dmitriev AA; Sakharov NN
    Sov Med; 1977 Oct; (10):95-9. PubMed ID: 929280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.